Compounds > cyclohexanol
Page last updated: 2024-08-18

cyclohexanol and Heart Defects, Congenital

cyclohexanol has been researched along with Heart Defects, Congenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artama, M; Engeland, A; Furu, K; Gissler, M; Haglund, B; Kieler, H; Malm, H; Nørgaard, M; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H1
Dolman, C; Howard, LM; Khalifeh, H1

Other Studies

2 other study(ies) available for cyclohexanol and Heart Defects, Congenital

ArticleYear
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    BMJ (Clinical research ed.), 2015, Apr-17, Volume: 350

    Topics: Adult; Cohort Studies; Contraindications; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Logistic Models; Odds Ratio; Population Surveillance; Pregnancy; Pregnancy Complications; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Siblings; Venlafaxine Hydrochloride

2015
Safety of psychotropic drugs in pregnancy.
    BMJ (Clinical research ed.), 2015, May-13, Volume: 350

    Topics: Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors

2015